Hydroxyapatite in tissue engineering and regenerative medicine: A patent landscape analysis of technological milestones and the road to clinical translation
Year: 2026
Type: article
Abstract: Hydroxyapatite (HA) has transitioned from a basic osteoconductive scaffold to a sophisticated, multifunctional platform in regenerative medicine. This study provides a comprehensive analysis of the HA patent landscape from 1975 to 2025, mapping the technological trajectory from foundational structural materials to advanced 3D-bioprinted and stem cell-integrated systems. Through a highly restrictive methodological filter (Title/Claims), our findings dispel the apparent volume dominance of emerging markets. We reveal that entities in the United States and Europe absolutely dominate the core inventive landscape in both filing volume and technical maturity, whereas most Asian academic filings fail to meet strict novelty parameters. We identify critical systemic bottlenecks, including regulatory fragmentation and the persistent “valley of death” between laboratory innovation and commercial availability. Furthermore, emerging gaps in sustainable biowaste-derived production and intelligent bio-interactivity are highlighted as strategic opportunities for future R&D. By aligning intellectual property trends with clinical demands, this work offers a roadmap for navigating the complex translational ecosystem of next-generation biomaterials.
Source: World Patent Information
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Open Access status: hybrid
Estimated APC paid: $3,653
OpenAlex ID: W7168408272
